Leading data-driven global platform for rare disease diagnosis

About Centogene

Founded in 2006, Centogene is the world’s leading rare disease diagnostic platform.

The company has the most comprehensive curated database of genotype-phenotype correlations and clinical data on rare inherited diseases, collected from physicians and clinics in over 110 countries.

Based on its in-depth disease knowledge and diagnostic testing activities, Centogene offers pharmaceutical companies high-quality patient identification/monitoring and biomarker development services.